MeDeChir: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MeDeChir
Largest movements
- Tangible fixed assets +€44,115
up €44,115 (+4926.9%), from €895 to €45,011
- Cash -€26,851
down €26,851 (-22.3%), from €120,483 to €93,632
mainly Contributions, distributions and other (-€104,500) and Investment in fixed assets (net) (-€46,727)
- Receivables within one year -€7,735
down €7,735 (-77.1%), from €10,031 to €2,297
- Other debts +€8,529
up €8,529 (+8.2%), from €103,552 to €112,081
- Gross operating margin +€7,861
up €7,861 (+5.6%), from €139,617 to €147,478
- Taxes +€5,151
up €5,151 (+14.8%), from €34,891 to €40,042
- Depreciation +€1,717
up €1,717 (+191.7%), from €895 to €2,612
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €132,253 | €140,955 | +€8,702 | +6.6% |
| Fixed assets | 21/28 | €911 | €45,027 | +€44,115 | +4840.4% |
| Tangible fixed assets | 22/27 | €895 | €45,011 | +€44,115 | +4926.9% |
| Furniture and vehicles | 24 | €895 | €45,011 | +€44,115 | +4926.9% |
| Financial fixed assets | 28 | €16 | €16 | = | 0.0% |
| Current assets | 29/58 | €131,342 | €95,929 | -€35,413 | -27.0% |
| Amounts receivable within one year | 40/41 | €10,031 | €2,297 | -€7,735 | -77.1% |
| Other amounts receivable | 41 | €10,031 | €2,297 | -€7,735 | -77.1% |
| Cash at bank and in hand | 54/58 | €120,483 | €93,632 | -€26,851 | -22.3% |
| Deferred charges and accrued income | 490/1 | €828 | - | -€828 | |
| Total equity and liabilities | 10/49 | €132,253 | €140,955 | +€8,702 | +6.6% |
| Equity | 10/15 | €20,807 | €20,945 | +€138 | +0.7% |
| Contributions | 10/11 | €20,460 | €20,460 | = | 0.0% |
| Outside capital | 11 | €20,460 | - | -€20,460 | |
| Share premium | 1100/10 | €20,460 | - | -€20,460 | |
| Profit (loss) carried forward | 14 | €347 | €485 | +€138 | +39.8% |
| Amounts payable | 17/49 | €111,446 | €120,010 | +€8,564 | +7.7% |
| Amounts payable within one year | 42/48 | €111,446 | €120,010 | +€8,564 | +7.7% |
| Trade debts | 44 | €4,822 | €4,902 | +€80 | +1.7% |
| Suppliers | 440/4 | €4,822 | €4,902 | +€80 | +1.7% |
| Taxes, remuneration and social security | 45 | €3,072 | €3,027 | -€45 | -1.5% |
| Taxes | 450/3 | €3,072 | €3,027 | -€45 | -1.5% |
| Other amounts payable | 47/48 | €103,552 | €112,081 | +€8,529 | +8.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €895 | €2,612 | +€1,717 | +191.7% |
| Other operating charges | 640/8 | €682 | €209 | -€474 | -69.4% |
| Gross operating margin | 9900 | €139,617 | €147,478 | +€7,861 | +5.6% |
| Operating profit (loss) | 9901 | €138,039 | €144,657 | +€6,618 | +4.8% |
| Financial income | 75/76B | €74 | €140 | +€65 | +88.0% |
| Recurring financial income | 75 | €74 | €140 | +€65 | +88.0% |
| Financial charges | 65/66B | €114 | €117 | +€3 | +2.4% |
| Recurring financial charges | 65 | €114 | €117 | +€3 | +2.4% |
| Profit (loss) for the period before taxes | 9903 | €137,999 | €144,680 | +€6,681 | +4.8% |
| Income taxes | 67/77 | €34,891 | €40,042 | +€5,151 | +14.8% |
| Profit (loss) for the period | 9904 | €103,108 | €104,638 | +€1,530 | +1.5% |
| Profit (loss) for the period to be appropriated | 9905 | €103,108 | €104,638 | +€1,530 | +1.5% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.